These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Vaccine-linked chemotherapy improves cardiac structure and function in a mouse model of chronic Chagas disease. Jones KM; Mangin EN; Reynolds CL; Villanueva LE; Cruz JV; Versteeg L; Keegan B; Kendricks A; Pollet J; Gusovsky F; Bottazzi ME; Hotez PJ Front Cell Infect Microbiol; 2023; 13():1106315. PubMed ID: 36844399 [TBL] [Abstract][Full Text] [Related]
23. Chagas cardiomyopathy is associated with a high susceptibility to T. cruzi infection in monocyte-derived macrophages and a predominance of CD4 Carvalho AMRS; Ferraz IA; Hojo-Souza NS; Medeiros FAC; Viana LA; Bartholomeu DC; Chaves AT; de Souza TM; Costa E Silva MF; Mendes TAO; Duarte MC; Rocha MODC; Menezes-Souza D Acta Trop; 2023 Jan; 237():106749. PubMed ID: 36370753 [TBL] [Abstract][Full Text] [Related]
24. Myocardial gene and protein expression profiles after autoimmune injury in Chagas' disease cardiomyopathy. Cunha-Neto E; Teixeira PC; Fonseca SG; Bilate AM; Kalil J Autoimmun Rev; 2011 Jan; 10(3):163-5. PubMed ID: 20883825 [TBL] [Abstract][Full Text] [Related]
25. Elevated serum levels of macrophage migration inhibitory factor are associated with progressive chronic cardiomyopathy in patients with Chagas disease. Cutrullis RA; Petray PB; Schapachnik E; Sánchez R; Postan M; González MN; Martín V; Corral RS PLoS One; 2013; 8(2):e57181. PubMed ID: 23451183 [TBL] [Abstract][Full Text] [Related]
26. Differential expression profile of genes involved in the immune response associated to progression of chronic Chagas disease. Gómez I; López MC; Egui A; Palacios G; Carrilero B; Benítez C; Simón M; Segovia M; Carmelo E; Thomas MC PLoS Negl Trop Dis; 2023 Jul; 17(7):e0011474. PubMed ID: 37440604 [TBL] [Abstract][Full Text] [Related]
34. Chagasic cardiomyopathy is marked by a unique signature of activated CD4 Almeida GG; Rimkute I; do Vale INPC; Liechti T; Henriques PM; Roffe E; de Araújo FF; da Costa Rocha MO; Santos SME; Martins-Filho OA; Jankovic D; Sher A; Teixeira-Carvalho A; Roederer M; do Valle Antonelli LR J Transl Med; 2022 Nov; 20(1):551. PubMed ID: 36447264 [TBL] [Abstract][Full Text] [Related]
35. Activation of Human CD11b Passos LSA; Magalhães LMD; Soares RP; Marques AF; Alves MLR; Giunchetti RC; Nunes MDCP; Gollob KJ; Dutra WO Front Immunol; 2018; 9():3015. PubMed ID: 30662439 [TBL] [Abstract][Full Text] [Related]
36. Autoimmunity in Chagas disease cardiopathy: biological relevance of a cardiac myosin-specific epitope crossreactive to an immunodominant Trypanosoma cruzi antigen. Cunha-Neto E; Duranti M; Gruber A; Zingales B; De Messias I; Stolf N; Bellotti G; Patarroyo ME; Pilleggi F; Kalil J Proc Natl Acad Sci U S A; 1995 Apr; 92(8):3541-5. PubMed ID: 7536937 [TBL] [Abstract][Full Text] [Related]
37. Autoimmunity in Chronic Chagas Disease: A Road of Multiple Pathways to Cardiomyopathy? De Bona E; Lidani KCF; Bavia L; Omidian Z; Gremski LH; Sandri TL; de Messias Reason IJ Front Immunol; 2018; 9():1842. PubMed ID: 30127792 [TBL] [Abstract][Full Text] [Related]